PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fifteen analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and […]
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fifteen analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and […]
